Skip to content
RDL Network logo
TCT-11 Five-year Follow up of the First in Man use of a Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis; A Serial Multi-Imaging Modality Study — Patrick W. Serruys (2015) | RDL Network